United States· US:66993-586_0318e892-0db1-4a82-a649-9e530a2d1d05
Fluticasone Propionate and Salmeterol
A corticosteroids, potent (group iii) product containing fluticasone propionate and salmeterol, registered in United States by Prasco Laboratories. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Fluticasone propionate and salmeterol is registered in 2 of 19 countries.
Countries holding a registration under ATC D07AC (corticosteroids, potent (group iii)), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Fluticasone propionate and salmeterol · ATC D07AC
2 / 19 countries
- Italyprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- fluticasone propionate and salmeterol
- Manufacturer
- Prasco Laboratories
- Country
- United States (US)
- ATC code
- D07AC
- ATC class
- Corticosteroids, potent (group III)
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1166993586971 INHALER in 1 CARTON (66993-586-97) / 60 POWDER in 1 INHALER
Regulatory notes
Same class
Other records under D07AC
Corticosteroids, potent (group iii), as other registers publish it.
- ItalyASMANEX*polv inal 30 dosi 400 mcgORGANON ITALIA Srl
- ItalyASMANEX*polv inal 60 dosi 200 mcgORGANON ITALIA Srl
- ItalyFLIXODERM*ung derm 30 g 0,05 mg/gGLAXOSMITHKLINE SpA
- ItalyFLIXOTIDE 250*polv inal 60 dosi 250 mcgGLAXOSMITHKLINE SpA
- ItalyFLIXOTIDE 50*sosp inal 120 erog 50 mcgGLAXOSMITHKLINE SpA
- ItalyFLIXOTIDE 500*60 dosi 500 mcg polv inalGLAXOSMITHKLINE SpA
- ItalyFLUGENIX*sosp nebul 20 contenitori monod 2 ml 2 mg/2 mlGENETIC SpA
- ItalyFLUGENIX*sosp nebul 20 contenitori monod 2 ml 500 mcg/2 mlGENETIC SpA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec246578-fc56-46ae-93d9-764a2869ec8a GET /v1/drugs/ec246578-fc56-46ae-93d9-764a2869ec8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "O2GMZ0LF5W",
"rxcui": "50121",
"inchikey": "WMWTYOKRWGGJOA-CENSZEJFSA-N",
"display_name": "FLUTICASONE PROPIONATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "RESPIRATORY (INHALATION)",
"spl_meta": {
"da4e897e-9be1-499a-8889-15398b30ef3b": {
"match": "brand_token",
"title": "FLUTICASONE PROPIONATE DISKUS (FLUTICASONE PROPIONATE) POWDER, METERED [A-S MEDICATION SOLUTIONS]",
"spl_version": "1",
"published_date": "2026-05-20"
}
},
"productid": "66993-586_0318e892-0db1-4a82-a649-9e530a2d1d05",
"productndc": "66993-586",
"dosage_form": "POWDER",
"orange_book": {
"appl_no": "021077",
"products": [
{
"rs": true,
"rld": true,
"te_code": "AB",
"strength": "0.1MG/INH;EQ 0.05MG BASE/INH",
"product_no": "001",
"approval_date": "Aug 24, 2000"
},
{
"rs": true,
"rld": true,
"te_code": "AB",
"strength": "0.25MG/INH;EQ 0.05MG BASE/INH",
"product_no": "002",
"approval_date": "Aug 24, 2000"
},
{
"rs": true,
"rld": true,
"te_code": "AB",
"strength": "0.5MG/INH;EQ 0.05MG BASE/INH",
"product_no": "003",
"approval_date": "Aug 24, 2000"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE",
"shortage_reason": "Fluticasone Propionate; Salmeterol Xinafoate Powder",
"shortage_status": "current",
"proprietary_name": "Fluticasone Propionate and Salmeterol",
"active_ingred_unit": "ug/1; ug/1",
"application_number": "NDA021077",
"marketing_category": "NDA AUTHORIZED GENERIC",
"nonproprietary_name": "fluticasone propionate and salmeterol",
"start_marketing_date": "20190208",
"active_numerator_strength": "500; 50"
}See everything about fluticasone propionate and salmeterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.